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Abstract
Background: Computational identification of blood-secretory proteins, especially proteins with differentially 
expressed genes in diseased tissues, can provide highly useful information in linking transcriptomic data to proteomic 
studies for targeted disease biomarker discovery in serum.
Results: A new algorithm for prediction of blood-secretory proteins is presented using an information-retrieval 
technique, called manifold ranking. On a dataset containing 305 known blood-secretory human proteins and a large 
number of other proteins that are either not blood-secretory or unknown, the new method performs better than the 
previous published method, measured in terms of the area under the recall-precision curve (AUC). A key advantage of 
the presented method is that it does not explicitly require a negative training set, which could often be noisy or 
difficult to derive for most biological problems, hence making our method more applicable than classification-based 
data mining methods in general biological studies.
Conclusion: We believe that our program will prove to be very useful to biomedical researchers who are interested in 
finding serum markers, especially when they have candidate proteins derived through transcriptomic or proteomic 
analyses of diseased tissues. A computer program is developed for prediction of blood-secretory proteins based on 
manifold ranking, which is accessible at our website http://csbl.bmb.uga.edu/publications/materials/qiliu/
blood_secretory_protein.html.
Background
Identification of disease markers in serum represents a
very important problem, but it is rather challenging due
to the composition complexity and the large dynamic
range of proteins in human sera, which makes direct
comparative analyses of serum proteomic data between
diseased and control samples exceedingly difficult [1,2].
What can possibly alleviate the problem is to carry out
such comparative analyses among a group of candidate
protein markers rather than searching through the whole
serum proteome in blind. The candidate markers could
be suggested by differential analyses based on microarray
gene expression or proteomic data of diseased versus
control tissues [3]. The basic idea is to first identify genes
or proteins with abnormal expression patterns in dis-
eased versus control tissues, which represents a substan-
tially simpler problem other than direct comparative
proteomic analyses of serum marker identification, and
then determine if the abnormally expressed proteins may
possibly get secreted into blood [3-5]. The challenge in
addressing the second part of the problem lies in the real-
ity that our current understanding is rather limited about
which of the expressed proteins in tissues may get
secreted into blood circulation. To address this problem,
we have developed the first computational method for
prediction of blood-secretory proteins, using a data min-
ing approach [6]. Specifically, a number of sequence,
physicochemical and structural features of proteins, such
as signal peptides, transmembrane domains, glycosyla-
* Correspondence: qyang@cse.ust.hk, xyn@csbl.bmb.uga.edu
3 Department of Computer Science and Engineering, Hong Kong University of 
Science and Technology, Hong Kong, China
2 Computational Systems Biology Laboratory, Department of Biochemistry and 
Molecular Biology, and Institute of Bioinformatics, University of Georgia, 
Athens, GA 30602, USA
Full list of author information is available at the end of the articleLiu et al. BMC Bioinformatics 2010, 11:250
http://www.biomedcentral.com/1471-2105/11/250
Page 2 of 8
tion sites, disordered regions, secondary structural con-
tent and hydrophobicity were identified, which can
potentially distinguish blood-secretory from non-blood-
secretory proteins. Using these features, a classifier based
on support vector machine (SVM) was trained to distin-
guish the blood-secretory proteins from non-blood-
secretory proteins.
One challenging problem in solving the so-defined
blood-secretory prediction is that we did not have a clean
dataset of non-blood-secretory proteins as the negative
training data, a common issue encountered across many
biological problems. In our previous work [6], we have
taken a rather conservative approach in selecting the neg-
ative dataset by leaving out a significant fraction of pro-
teins which could potentially be non-blood secretory
proteins; hence the data may not adequately represent the
whole space of the non-blood-secretory proteins.
In this study, we tackle this problem from a different
perspective. We intend to rank the positive data out of
the background data instead of to classify them from the
rest of the background. An information retrieval tech-
nique, so called manifold ranking [7], was employed to
rank all the candidate proteins according to the possibil-
ity of being blood-secreted, which is a semi-supervised
prediction model. Its main difference from our previous
classification-based approach is that it requires no nega-
tive set but only a positive set and a background set.
Ranking techniques have been successfully applied to
solve various biological probelms. For example, RANK-
Prop used the ranking technique for remote homology
detection [7-9]. Owen et al. developed a ranking tech-
nique-based algorithm for identification of co-expressed
genes [10]. GeneRank ranks genes in terms of their rele-
vance to a particular stimulus based on changes in their
expression levels, using a very similar idea to that of the
Google PageRank algorithm [11,12]. miRank is a recent
algorithm for predicting microRNAs [13], also employing
a ranking technique.
It should be noted that classification techniques like
SVM can also be used to rank data samples, according to
their distances to the separating hyperplane in the feature
space [14,15]. Nevertheless, manifold ranking has proved
to be superior in this regard [7], due to its well-developed
transductive ability to fully utilize the mutual relation-
ships among the provided data. One potential drawback
with the manifold ranking method, compared to an SVM,
is that it is computationally more expensive, given that its
computational complexity is O(n3) for a dataset of n sam-
ples [7,9]. In our case, n, the number of inclusive proteins,
could be 20-30 K or larger. To deal with this computa-
tional issue, we have employed an efficient filtering pro-
cedure to reduce the initial set of candidate proteins to
ensure that our predictor runs efficiently without sub-
stantially lowering the prediction accuracy.
Methods
A. Datasets
Two datasets were used in this study. One is consisting of
305 experimentally validated human blood-secretory
proteins and 14,770 non-blood-secretory proteins [6],
which were divided into a training set of 253 positive
samples and 11,141 negative samples and a test set with
the remaining 52 positive samples and 3,629 negative
samples. Another dataset is the well-curated human pro-
teome from Swissprot [16], containing 20,309 human pro-
teins.
We continue to use the same set of features identified in
our previous work [6], such as signal peptides, transmem-
brane domains, glycosylation sites, disordered regions,
secondary structural content and hydrophobicity, by
which each protein is represented as a 85-dimensional
feature vector (see additional file 1 for details).
B. A computational framework for ranking blood-secretory 
proteins
We now present a computational framework for blood-
secretory protein prediction, consisting of the following
steps as shown in Figure 1: (a) a pre-processing step is
employed to filter out the most irrelevant proteins to the
positive samples, based on the criteria described in sub-
section F; (b) a weighted graph is constructed as the main
data structure for solving our ranking problem, based on
the remaining proteins from (a). (c) This graph is sparsi-
fied with an efficient algorithm for further manifold rank-
ing, which will be elaborated in subsection D; (d) a semi-
supervised ranking algorithm is applied on the con-
structed graph to rank the proteins; and (d) output the N
highest ranked proteins, where N  is a user-specified
parameter. Note that proteins with higher ranks are
intended to have higher probabilities for being blood-
secretory.
C. A ranking algorithm
The essence of a manifold ranking algorithm [7,9,17] can
be intuitively explained: the problem is defined on two
datasets, a true sample set and an unknown sample set
(background); and the goal is to rank the individual mem-
bers of the unknown sample set according to their rele-
vance to the true samples. A weighted graph is used to
represent the whole sample set, with each sample being
represented as a node of the graph and each pair of nodes
being represented as an edge with a weight defined as the
similarity between the two nodes in the feature space.
Then an evidence propagation process starts, in which
each true sample propagates its presence (as an evidence)
to its neighbouring nodes to increase their relevance to
the true sample set, where the increased relevance is val-
ued proportionally to the corresponding edge weight in
the graph. An overall relevance score of each node isLiu et al. BMC Bioinformatics 2010, 11:250
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summed over all the scores propagated to itself from all
the related true samples, by which the unknown samples
can be ranked eventually.
Formally, given is a set of points X = (x1... xq, xq + 1... xn)
in Rm (m is the dimension of the feature space), with the
first q points being the known blood-secretory proteins
and the remaining (n-q) being the unknown proteins. Let
f : X T R be a ranking function that assigns each point xi a
ranking score f(xi). Define y = [y1... yn]T with yi = 1 if xi is a
true sample and yi = 0 otherwise. The aim of the ranking
algorithm is to obtain a final ranking score f* for each pro-
tein through a procedure given as follows:
Input: A set of points X = (x1... xq, xq + 1... xn) in Rm with
the first q points being true samples, and the initial score y.
Define f0 = y; and σ, α are two parameters of the program.
Figure 1 General computational framework in our study.Liu et al. BMC Bioinformatics 2010, 11:250
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Output: A ranked list of X, with higher ranked proteins
being more likely to be blood-secretory proteins.
1. Define the edge-weight matrix (graph) Wij = exp(-||xi -
xj||2/2σ2) and Wii = 0. Some of the edges can be removed
using a graph sparsification procedure described in the
next subsection;
2. Compute L = D-1/2WD-1/2 with D being a diagonal
matrix defined as  ;
3. Set iteratively ft+1 = αLft + (1-α)y until f converges,
where α is a parameter in [0, 1);
4. Let f* be the converged function ft; and rank all the
points {xi} in the decreasing order of their f* values.
It has been shown [7] that f* converges to the following
A detailed description of equation (1) is given in [9].
The two free parameters σ and α are defined as follows: σ
defines the local affinities among all the data points while
α controls the level of effect of the positive-sample propa-
gation. Note that the effect of σ on the affinity matrix W
wil l be  c oun t e ra ct ed by  norm a liza t ion L = D-1/2WD-1/2
and will not contribute to the final ranking. In our study
we have empirically set  , where   is the average
distance between all pair samples in a given dataset [18].
We set α = 0.5 based on our 10-fold cross-validation on
the test dataset. To tune this parameter, we searched the
optimal value of α from 0 to 1 with step 0.1. For each
value, the positive samples in the test dataset were
divided into 10 folds and the ranking is performed based
on one subset as queries, and validated based on the com-
bination of other nine subsets. This procedure was per-
formed 10 times and the validation results are averaged
over the rounds. Finally we selected the optimal value of α
from (0,1] according to the corresponding validated rank-
ing performance.
It should be noted that this ranking algorithm is differ-
ent from sequence similarity-based algorithms such as
BLAST [19], as we measure the relevance between the
blood-secreted and non-blood-secreted proteins in terms
of a set of biologically meaningful features.
D. Edge removal from our graph
Note that some of the edges in the graph defined in Sec-
tion C do not really contribute to the correct ranking; so
we consider having such edges removed to ensure that
the ranking algorithm remains efficient and robust in the
presence of noise. Here, we applied a graph-sparsification
method to construct a sparse graph from a fully con-
nected weighted graph obtained from the previous steps.
Formally, for the matrix W ￿ Rn×n calculated in Section
C, we first find a binary matrix P that maximizes the fol-
lowing objective function under the specified constraints:
This optimization problem can be solved using a
recently published algorithm, called a loopy belief propa-
gation method [20]. We keep an edge in the graph defined
in Section C only if its corresponding value in P is 1, and
then recalculated the weights of the re-defined graph as
follows:
which gives a highly sparse graph without loss of the
essential information for the ranking purpose [18,20].
Recent reports indicate that this sparsification procedure
can be implemented efficiently using a belief propagation
algorithm that ensure to obtain the global solution in
cubic time of the number of nodes in the graph [18,20],
which we have done.
E. Performance evaluation
We have used the following parameter to evaluate the
prediction performance of blood-secretory proteins. The
area under curve (AUC) of the recall-precision curve [22]
was calculated as a prediction accuracy evaluation:
where TP, FP and FN are numbers of true positive pre-
dictions, false positive predictions and false negative pre-
dictions, respectively.
F. Filtering
The computation complexity of the ranking algorithm is
O(n3), where n  is the number of samples [7], possibly
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causing problems when applied to large sample sizes. To
overcome this issue, we have filtered out the majority of
the most irrelevant unknown samples by ranking them
according to their nearest distance to the known blood-
secreted protein samples. We filter out k unknown sam-
ples from the bottom of the ranking according to such a
distance, with k being a user specified parameter. Note
that we have to calculate the pairwise distances among
samples to define the affinity matrix W in the first step,
thus additional computational time has to be introduced
by this filtering step but without increasing the asymp-
totic computational complexity of the whole algorithm.
G. Universal manifold ranking with both positive and 
negative samples
When both positive and negative training data are avail-
able, we can extend the above manifold ranking algorithm
to take advantage of the availability of negative training
data, giving rise to the so-called universal manifold rank-
ing, an idea initially employed in [9], and we refer the
above original manifold ranking algorithm based on posi-
tive training data as the positive-samples-only-based
manifold ranking algorithm.
A high-level idea of the universal manifold ranking
algorithm can be outlined as follows. When both positive
and negative samples are used for training, each of the
two datasets affects the overall ranking differently. In
principle, positive examples should make more contribu-
tions to the final ranking than negative examples since for
an unlabeled data, the farther it lies from positive exam-
ples in the feature space, the less possible it is a positive
one, which in general does not have to be case for nega-
tive examples [9].
Specifically, we have two initial score vectors y+ and y-.
An element of the former is set to 1 if the corresponding
sample is blood-secretory, and the element of the latter is
set to -1 if the corresponding sample is not blood-secre-
tory. All the other elements of the two vectors are set to 0.
According to equation (1), we denote A = (1 - a)(I - aL)-1
and define two matrices A+ and A-, which are used to
propagate the ranking scores of both the positive and
negative examples, i.e., f+* = A+y+, f-* = A-y-, where f+* and
f-* are the ranking scores obtained from positive and neg-
ative samples, respectively. The final ranking score can be
written as:
In our current implementation, we have A+ = A and A- =
γA+, with γ ￿ (0, 1] being a parameter that controls the
contribution of the negative samples to the final ranking
by f*.
Results and Discussion
In this study, we continue to use the same human protein
dataset from our previous work [6]. We have carried out a
detailed analysis of our prediction results as follows.
Performance on independent test data
305 experimentally validated blood-secretory proteins
and 14,770 non-blood-secretory proteins have been col-
lected. Each of these proteins is represented using an 85-
dimensional feature vector. In our previous study [6], this
dataset was divided into a training set with 253 positive
samples and 11,141 negative samples, and a test set with
52 positive samples and 3,629 negatives. Here, we used
the same test set through the following evaluation proce-
dure to assess the comparison performance:
(1) We randomly selected 10, 20 and 30 blood-secre-
tory proteins from the test dataset as the queries and rank
all the 3,681 proteins in the test set using the positive-
samples-only-based manifold ranking and SVM-based
algorithm. W e repeat this procedure five times and the
average performance results were used for performance
assessment. The reason for us to use three different sets
of queries is obvious: we want to prove that the manifold
ranking is universally superior to SVM-based ranking
methods with different numbers of known positive sam-
ples. It should be noted that it is difficult to directly com-
pare manifold ranking with SVM-based classification
results, since the latter involves class labels while the for-
mer does not. To overcome the issue, we adapted two
comparison strategies: (1). we followed a strategy pre-
sented by Xue et al. [21], and trained three SVM-based
models with the selected 10, 20 and 30 queries as the pos-
itive training samples, respectively; and we included N
times negative samples of the positive ones in the training
set, where N  is determined through trial-an-error to
achieve the best classification results for the whole test
dataset. Then the whole test proteins were ranked
according to their positive distances (probabilities) to the
trained SVM hyperplane. (2). To be more strictly, we also
compared the positive-samples-only-based manifold
ranking with one-class SVM algorithm presented by John
B.S. et al. [22], with selected 10, 20 and 30 blood-secre-
tory proteins as the positive samples. In such one-class
SVM model, the whole test proteins were also ranked
according to their positive distances (probabilities) to the
trained SVM hyperplane.
(2). We then added the positive samples (253) and the
negative samples (11,141) in the training set to the test set
as queries to perform the universal manifold ranking. The
idea is that we only kept the test data as an independent
evaluation set. The samples in the training dataset were
either used as labelled data to train the SVM for predic-
tion on the test set, or used as queries to rank the samples
ff f
∗+ ∗− ∗ =+ (6)Liu et al. BMC Bioinformatics 2010, 11:250
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i n  t h e  t e s t  s e t .  T h i s  i s  d e s i g n e d  f o r  a  f a i r  c o m p a r i s o n
between the two methods.
The performance by the positive-samples-only-based
manifold ranking and SVM-based ranking on the inde-
pendent test data is shown in Tables 1. It should be noted
that in the first comparison strategy of SVM-based rank-
ing, 250,130 and 110 times negative samples of the posi-
tive ones were heuristically selected for 10, 20 and 30
positive samples, to train an optimized SVM models,
respectively. That is, 2,500, 2,600 and 3,300 negative sam-
ples were selected for 10, 20 and 30 positive samples
incorporated with an exhaustive search of aforemen-
tioned in a range of [10:300] and the evaluations on the
test dataset achieved the best accuracies at 98%, 99% and
99%, respectively. From Tables 1, we can see that the
manifold ranking achieved the average best ranking result
for all 3 groups of queries compared with both two kinds
of SVM-based ranking.
Table 2 presents the performance on the test dataset
based on the queries from training datasets, i.e., the SVM
model is trained on the training datasets with 253 posi-
tive samples and 11,141 negative samples and the univer-
sal manifold ranking is performed with the same training
samples as queries. A 10-fold cross-validation test has
been performed and the SVM classifier can achieve ~98%
accuracy on the test set. Here, we presented the general
recall-precision curve on the whole test set with the
whole training set as queries, which shows the corre-
sponding prediction precision at each sensitivity (recall)
level (Figure 2). It can be seen that, in this case, the uni-
Table 1: Performance comparisons on independent test dataset for manifold ranking and SVM-based ranking
AUC
No. of 
queries
Methods 12345 A v e .
10 MR 0.7412 0.6565 0.6342 0.6355 0.6576 0.6650
SVM-1 0.6342 0.6224 0.6571 0.6317 0.5964 0.6284
SVM-2 0.6425 0.6342 0.6521 0.6218 0.6091 0.6319
20 MR 0.7920 0.7629 0.7657 0.7574 0.8046 0.7765
SVM-1 0.6768 0.6535 0.6373 0.6371 0.6895 0.6589
SVM-2 0.6928 0.6634 0.6823 0.6576 0.6797 0.6752
30 MR 0.8245 0.8283 0.8170 0.8072 0.8655 0.8285
SVM-1 0.7388 0.7800 0.8014 0.7864 0.7759 0.7765
SVM-2 0.7818 0.8167 0.8023 0.7689 0.7909 0.7921
(Both rankings were performed with 10, 20 and 30 queries, evaluated by AUC of recall-precision curve. (Parameter setting: σ = 2.7003 and α = 
0.5. Each kind of query is performed 5 times. MR: Manifold ranking; SVM-1: first strategy of SVM-based ranking; SVM-2: one-class SVM-based 
ranking)
Table 2: Performance comparisons on independent test dataset for the universal manifold ranking and SVM-based 
ranking
MR SVM
AUC 0.6663 0.6592
(Both rankings were performed with a different dataset as training set, evaluated by AUC of recall-precision curve. Parameter setting: σ = 
2.7003 and α = 0.5. MR: Manifold ranking; SVM: SVM-based ranking)Liu et al. BMC Bioinformatics 2010, 11:250
http://www.biomedcentral.com/1471-2105/11/250
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versal manifold ranking method is superior to SVM-
based ranking.
Manifold ranking on all known human proteins
We have used the 305 known blood-secretory proteins as
queries to perform our positive-samples-only-based man-
ifold ranking of the whole set of 20,309 known human
proteins collected from Swissprot  [16]. The top-1,000
ranked proteins are given in additional file 2.
This ranking list can be viewed as a set of blood-secre-
tory protein candidates for further experimental valida-
tions. Among these proteins, the top 305 ones are exactly
the known blood-secreted proteins ordered by our rank-
ing algorithm, while the other 695 proteins are originally
considered as unknown but our prediction suggests that
they are highly probable to be blood-secreted. Before the
experimental validation on these predicted proteins, we
indeed have collected some evidences to support some of
our predictions. For example, protein Cadherin-12
(P55289), ranked as the 1st among the 695 proteins, has
been recently identified to be a serum biomarker by mul-
tidimensional chromatography [2], while being currently
annotated as a cell adhesion protein specifically
expressed in brain tissue in Swissprot [16].
We have carried out a functional enrichment analysis
on the top 1,000 proteins against the whole background
human protein set, according to the GO ontology. The
GOEAST (Gene Ontology Enrichment Analysis Software
Toolkit) was used [23] to carry out this analysis. The
comparison results in terms of three GO categories, i.e.,
biological process, cellular component and molecular
function are listed in additional files 3, 4, 5. Since the GO
ontology is hierarchical, we picked the top three most sig-
nificantly enriched GO functional terms from the leaf
nodes of each GO hierarchy, respectively, as listed in
Table 3. We can see that these proteins are functionally
enriched with serine endopeptidases, which are reported
to serve functions in blood clotting, the immune system,
and inflammation [24]. As expected, most of these pro-
teins are membrane-associated proteins and related to
platelet granule secretion [25]. There are literature evi-
dences indicating that several serum biomarkers, such as
the serum prostate specific antigens (PSA) for prostate
cancer diagnosis, are shown to have higher levels of inter-
nal peptide bond cleavages and are more enzymatically
inactive [26,27], thus it is particular interesting that we
found the biological process of regulation of protein mat-
uration by peptide bond cleavage is highly enriched in
our dataset.
Conclusion
In this study, we modelled the problem of blood-secre-
tion prediction as a ranking instead of a classification
problem, where novel blood-secretory proteins were
ranked based on their relevance of a group of experimen-
tally validated blood-secretory proteins. Our evaluation
results have shown that the ranking algorithm is robust,
efficient and achieved a superior prediction result than an
SVM-based prediction method. We have presented the
Figure 2 Recall-precision curve of the ranking results on the 
whole test dataset given the whole training dataset as queries.
Table 3: Top 3 functional enrichment GO terms for the top 1,000 proteins provided by manifold ranking, annotated with 3 
GO categories.
molecular_function cellular_component biological_process
Top 1 GO:0004867: serine-type 
endopeptidase inhibitor 
activity (3.56e-27)
GO:0031093: platelet alpha 
granule lumen (1.64e-21)
GO:0010953: regulation of 
protein maturation by peptide 
bond cleavage (0)
Top 2 GO:0004252: serine-type 
endopeptidase activity (6.64e-
14)
GO:0005606: laminin-1 
complex (3.74e-8)
GO:0006958: complement 
activation, classical pathway 
(4.2e-21)
Top 3 GO:0008201: heparin binding 
(8.14e-8)
GO:0005579: membrane 
attack complex (3.74e-8)
GO:0006957: complement 
activation, alternative 
pathway (2.05e-16)Liu et al. BMC Bioinformatics 2010, 11:250
http://www.biomedcentral.com/1471-2105/11/250
Page 8 of 8
first time a complete blood-secretory protein ranking list
on all human proteins, which is expected to well facilitate
the experimental approach for serum biomarker discov-
ery.
Availability
The human protein dataset and the related scripts can be
freely accessed at http://csbl.bmb.uga.edu/publications/
materials/qiliu/blood_secretory_protein.html.
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